The American Journal of Managed Care

What Would Make Therapy Last? How About 2 Targets Each on B Cells and T Cells?

The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...

B cells temporarily regain stem-like flexibility, increasing risk of lymphoma formation

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...
EurekAlert!

B cells transiently unlock their plasticity, risking lymphoma development

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...
Healio

‘Complete eradication’ of B cells drives remission after autoimmune CAR T-cell therapy

Please provide your email address to receive an email when new articles are posted on . A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the ...